Beam Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Beam Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Beam Therapeutics Inc
Rating: 1.211986125
Author: Trendlyne DVM scores

Momentum Trap

about

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases....

29.02 -1.68 (-5.47%)

114.64% Gain from 52W Low

2.1M

XNAS Volume

XNAS 28 Jan, 2026 4:30 PM (EST)

Low Financial Strength

11.1 / 100

Expensive Valuation

11.7 / 100

Technically Moderately Bullish

63.1 / 100

Momentum Trap These stocks have weak financials and expensive valuation. Buying interest may quickly dissipate. Investors should exercise caution View Similar Embed DVM

1Yr Price target upside is 63%

14 analysts

Beam Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Beam Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases....

114.64% Gain from 52W Low

SWOT Analysis

Beam Therapeutics Inc Live Price Chart